|
|||||
|
|
Reply to the article 'Hepatitis C virus (HCV) infection and MALT-type ocular adnexal lymphoma (OAL)' by P. Arnaud, M.-C. Escande, M. Lecuit et al. (Ann Oncol doi:10.1093/annonc/mdl369) |
|
| Authors: | Ferreri, AJM Dolcetti, R Musto, P Dognini, GP Doglioni, C Ponzoni, M |
| Affiliation: | 1 Medical Oncology Unit, San Raffaele Scientific Institute, Milan 2 Immunovirology and Biotherapy Unit, Department of Pre-Clinical and Epidemiological Research, Centro di Riferimento Oncologico, IRCCS National Cancer Institute, Aviano 3 U.O.C. di Ematologia e Trapianto di Cellule Staminali, Centro di Riferimento Oncologico di Basilicata, Ospedale Oncologico Regionale, Rionero in Vulture, Potenza 4 Pathology Unit, San Raffaele Scientific Institute, Milan, Italy |
| Abstract: | According to the interesting letter from Arnaud et al. [1],the prevalence of hepatitis C virus (HCV) infection in ocularadnexal lymphoma (OAL) patients diagnosed at the Institut Curieis 2%, which is significantly lower compared with the 13% observedin our series [2]. Intriguingly, the single French patient withOAL and HCV infection displayed a disseminated lymphoma andwas the sole patient who died of lymphoma progression, whichis in line with the negative prognostic |
| Keywords: | |
| 本文献已被 ScienceDirect Oxford 等数据库收录！ | |